Evaluation of the awareness of, attitude to, and knowledge about fertility preservation in cancer patients among clinical practitioners in Hong Kong

Chung, Jacqueline Pui Wah; Lao, Terence T.; Li, Tin‐Chiu

doi:10.12809/hkmj176840

Cited by 25 publications

(28 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The rate of women who were offered fertility preservation counseling is not available in our data set. Chung and colleagues in their survey among 457 clinicians in various public hospitals in Hong Kong, reported that only 45.6% were familiar with fertility preservation (28). The factors considered most important for referral were prognosis, patient's motherhood desire, time available before starting gonadotoxic treatment, type of cancer, and type of antiblastic therapy.…”

Section: Discussionmentioning

confidence: 99%

Oocyte Cryopreservation in Oncological Patients: Eighteen Years Experience of a Tertiary Care Referral Center

et al. 2019

View full text Add to dashboard Cite

Objective: The aim of the present study is to report our experience on elective women fertility preservation before cancer treatment.Study Design: This is a single-center retrospective observational study, including all patients who underwent elective fertility preservation before oncological treatment between January 2001 and March 2019 at our Institute.Results: Of a total of 568 women who received fertility counseling, 244 (42.9%) underwent 252 oocyte retrieval cycles after controlled ovarian stimulation for cryopreservation. The majority of patients were diagnosed with breast cancer (59.9%), followed by women affected by Hodgkin's and non-Hodgkin's lymphoma (27.4%). A minority comprised patients diagnosed with other malignancies that affected soft tissues (2.8%), ovary borderline type (2.4%), digestive system (1.6%), leukemia (1.6%), uterine cervix (1.2%). The remaining 3.1% were affected by other cancer types. The mean age of the cohort was 31.3 ± 6.4 years and the mean oocyte retrieval was 13.5± 8.4. Of 11 women who returned to attempt a pregnancy, three performed two thawed cycles. We obtained four pregnancies from 24 embryo transfers (Pregnancy Rate 36.4% for couple): two miscarriages and two live births. Overall, 95.7% of oocytes are still in storage.Conclusions: A close collaboration between Cancer and Fertility Center in a tertiary care hospital is essential to provide a good health service in oncological patients. Offering fertility preservation is no longer considered optional and must be included in every therapeutic program for women who receive an oncological diagnosis in their reproductive age. Oocyte cryopreservation appears to be a good opportunity for fertility preservation. Our results, although they are obtained in a small sample, are encouraging, even if only 4.5% of patients returned to use their gametes.

show abstract

Section: Discussionmentioning

confidence: 99%

Oocyte Cryopreservation in Oncological Patients: Eighteen Years Experience of a Tertiary Care Referral Center

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Results of this study 10 were surprising, to say the least. Without going into the specifics of different types of fertility preservation and their respective indications, less than half of the respondents (45.6%) reported being 'aware of fertility preservation' .…”

Section: Fertility Preservation In Young Cancer Patients As a Springbmentioning

confidence: 55%

“…In the article that accompanies this editorial, Chung et al 10 present the results of a cross-sectional paper-based survey that assessed the awareness of, attitude towards, and knowledge about fertility preservation among 167 clinicians of various clinical specialties in Hong Kong. Specialists in General Surgery, Paediatrics, Clinical and Medical Oncology, and Haematology and Haematological Oncology were included.…”

Section: Fertility Preservation In Young Cancer Patients As a Springbmentioning

confidence: 99%

Fertility preservation in young cancer patients as a springboard to address the needs of this unique population

Loong

2017

Hong Kong Med J

View full text Add to dashboard Cite

“…This may be because there is still no availability of fertility preservation in Indonesia. In Hong Kong, 45.6% of clinicians were familiar with fertility preservation 13 .…”

Section: Discussionmentioning

confidence: 99%

“…A similar study in Lebanon found that 90% of clinical practitioners and 94% of oncologists agreed to discuss fertility preservation with patients before cancer treatment 14 . Clinicians in Hong Kong did not refer patients to fertility specialists due to lack of available time before treatment, considerable risk of recurrence, poor prognosis, financial constraints, cancer treatment as top priority at the time, and lack of awareness of such service 13 .…”

Section: Discussionmentioning

confidence: 99%

Developing an Indonesian fertility preservation questionnaire for health care providers treating patients with cancer: A preliminary pilot study

et al. 2019

View full text Add to dashboard Cite

Background: Early detection and advanced treatment increases the five-year survival rate of patients with cancer. However, long-term cancer therapy, such as chemotherapy and radiotherapy, can have negative effects, such as infertility. This study aimed to develop a standardized Indonesian questionnaire, which would be used to assess the quality of health care providers’ knowledge, attitude, and practice regarding fertility preservation in patients with cancer. Methods: A pilot study was performed in January and February 2018 at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. An existing questionnaire was translated from English to Indonesian using forward translation, back translation, expert panel, pretesting, and cognitive interviewing. Ten subspecialists in the following departments made up an expert panel, who were involved in pretesting and cognitive interviewing: pediatric hematology-oncology, hematology-oncology/internal medicine, gynecologic oncology, gynecologic immune-endocrinology, radiology-oncology, and surgical oncology. Results: The questionnaire was successfully translated. The ten respondents stated that the maximum age for women’s fertility preservation is 40 years of age (60%), 45 years of age (30%), or had no maximum age (10%). Additionally, the respondents stated that the maximum age for men’s fertility preservation is 40 years of age (30%), 50 years of age (20%), or had no maximum age (50%). The respondents’ knowledge stated that > 50% of them were aware but do not know enough about fertility preservation. The respondents stated that more than 50% of them give feedback agreeing to fertility preservation, and they always give advice about fertility preservation to their patients. Conclusion: The translation of the questionnaire followed translation steps from the World Health Organization and was adjusted based on the expert panel’s comments concerning fertility preservation. This validated questionnaire tool in Indonesian can be used for research purposes and clinical evaluation of fertility preservation among health care providers in Indonesia.

show abstract

Evaluation of the awareness of, attitude to, and knowledge about fertility preservation in cancer patients among clinical practitioners in Hong Kong

Cited by 25 publications

References 11 publications

Oocyte Cryopreservation in Oncological Patients: Eighteen Years Experience of a Tertiary Care Referral Center

Oocyte Cryopreservation in Oncological Patients: Eighteen Years Experience of a Tertiary Care Referral Center

Fertility preservation in young cancer patients as a springboard to address the needs of this unique population

Developing an Indonesian fertility preservation questionnaire for health care providers treating patients with cancer: A preliminary pilot study

Contact Info

Product

Resources

About